Want to join the conversation?
$MRK 2Q15 Call: From an access perspective, BELSOMRA is now covered by commercial payers, representing over 100MM lives and a branded DTC campaign will be launched next week to enhance consumer awareness. KEYTRUDA is now the number one therapy used to treat melanoma in the US and KEYTRUDA will be launched in the EU.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?